Mehmet Alı Nahıt Şendur
机构：Ankara University, Bilkent University, Memorial Ankara Hospital, Başkent University Hospital, Ankara Yıldırım Beyazıt University, Ankara Bilkent City Hospital
发表论文 434 篇 · 总被引 4670 次 · h-index 28
代表论文
- Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 112)
- Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer (2025 · New England Journal of Medicine · 被引 55)
- PT1.03.06 Mechanisms of Acquired Resistance to First-Line Amivantamab Plus Lazertinib Vs Osimertinib: Updated Analysis from MARIPOSA (2025 · Journal of Thoracic Oncology · 被引 5)
- Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study (2025 · Frontiers in Immunology · 被引 2)
- Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey (2026 · Scientific Reports · 被引 1)
- Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience (2025 · BMC Cancer · 被引 1)